CVE:RVVRevive Therapeutics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Revive Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume32,500 shsAverage Volume93,085 shsMarket CapitalizationC$3.62 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsHeadlinesSocial Media Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Revive Therapeutics. Previous Next 2.4 Community Rank Outperform VotesRevive Therapeutics has received 58 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRevive Therapeutics has received 61 “underperform” votes. (Add your “underperform” vote.)Community SentimentRevive Therapeutics has received 51.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Revive Therapeutics and other stocks. Vote “Outperform” if you believe RVV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RVV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRevive Therapeutics does not currently pay a dividend.Dividend GrowthRevive Therapeutics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Revive Therapeutics insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Revive Therapeutics is -2.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Revive Therapeutics is -2.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:RVV Previous Symbol CUSIPN/A CIKN/A Webwww.revivethera.com Phone+1-905-6055535Debt Debt-to-Equity RatioN/A Current Ratio6.14 Quick Ratio6.03Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow3.18 Book ValueC$0.02 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares72,411,000Market CapC$3.62 million Next Earnings Date9/4/2020 (Estimated) OptionableNot Optionable TSXV:RVV Rates by TradingView Receive RVV News and Ratings via Email Sign-up to receive the latest news and ratings for RVV and its competitors with MarketBeat's FREE daily newsletter. Revive Therapeutics (CVE:RVV) Frequently Asked Questions When is Revive Therapeutics' next earnings date? Revive Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, September 4th 2020. View our earnings forecast for Revive Therapeutics. How were Revive Therapeutics' earnings last quarter? Revive Therapeutics Ltd (CVE:RVV) released its earnings results on Friday, May, 29th. The company reported ($0.02) EPS for the quarter. View Revive Therapeutics' earnings history. Has Revive Therapeutics been receiving favorable news coverage? News articles about RVV stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Revive Therapeutics earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Revive Therapeutics. Who are some of Revive Therapeutics' key competitors? Some companies that are related to Revive Therapeutics include Kane Biotech (KNE), Collagen Solutions (COS), Devonian Health Group (GSD), Hvivo (HVO), Realm Therapeutics (RLM), Bioxyne (BXN), Rhinomed (RNO), Naturally Splendid Enterprises (NSP), Medicure (MPH), biOasis Technologies (BTI), Anatara Lifesciences (ANR), Adalta (1AD), Ovoca Bio (OVB), Hemostemix (HEM) and Nuvo Pharmaceuticals (NRI). View all competitors. What other stocks do shareholders of Revive Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Revive Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aurora Cannabis (ACB), Aphria (APHA), BioCryst Pharmaceuticals (BCRX), Bristol-Myers Squibb (BMY), CytoDyn (CYDY), Enterprise Products Partners (EPD), EPR Properties (EPR) and GW Pharmaceuticals PLC- (GWPH). Who are Revive Therapeutics' key executives? Revive Therapeutics' management team includes the following people: Mr. Craig Leon, Chairman & CEO (Age 51)Mr. Fabio Chianelli, Pres & Director (Age 41)Mr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 48) What is Revive Therapeutics' stock symbol? Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV." How do I buy shares of Revive Therapeutics? Shares of RVV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. How big of a company is Revive Therapeutics? Revive Therapeutics has a market capitalization of C$0.00. What is Revive Therapeutics' official website? The official website for Revive Therapeutics is www.revivethera.com. How can I contact Revive Therapeutics? Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535. This page was last updated on 7/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
